FRAMINGHAM, Mass.--(BUSINESS WIRE)--SCIEX, a global leader in life science analytical technologies, announces that it will establish a Centre of Innovation at the Alderley Park Bio Hub, UK. SCIEX UK will relocate from its existing premises in Warrington to the new centre. The move will be completed in October 2020.
SCIEX’s technical support, demo and application development teams and laboratories will be based in the new SCIEX UK Centre of Innovation, which will provide support for SCIEX’s customers across Europe, the Middle East and Africa.
“Alderley Park is one of the leading life science hubs in Europe, with its superb laboratory facilities, purpose built infrastructure and network of the worlds most skilled science professionals. It is the perfect home for SCIEX to enhance our ability to serve customers through world class support and scientific collaboration,” says Christian Sauber, VP & GM EMEAI.
About SCIEX
SCIEX delivers solutions for the precision detection and quantification of molecules, empowering our customers to protect and advance the wellness and safety of all. We have led the field of mass spectrometry for 50 years. From the launch of the first ever commercially successful triple quadrupole in 1981, we have developed groundbreaking technologies and solutions that influence life-changing research and outcomes.
Today, as part of the Danaher (NYSE: DHR) family of global life science and technology innovators, we continue to pioneer robust solutions in mass spectrometry and capillary electrophoresis. Our customers are able to quickly respond to environmental hazards, better understand biomarkers relevant to disease, improve patient care in the clinic, bring relevant drugs to market faster and keep food healthier and safer.
That’s why thousands of life science experts around the world choose SCIEX to get the answers they can trust to better inform critical decisions that positively impact lives.
For more information, visit sciex.com.
